In Veritas Medical Diagnostics, Inc. (IVME)

IVME Income Statement

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Jul 31, 2007	Jul 31, 2006	Jul 31, 2005	Jul 31, 2004	Sep 30, 2003
Revenue	-	1.27	0.88	0.76	0.29
Revenue Growth (YoY)	-	44.47%	15.69%	165.45%	-
Cost of Revenue	-	-	0	0	0.01
Gross Profit	-	1.27	0.88	0.76	0.28
Selling, General & Admin	2.01	0.92	1.15	0.89	0.76
Research & Development	0.71	1.21	1.34	0.87	0.19
Operating Expenses	2.72	2.13	2.55	1.78	0.96
Operating Income	-2.72	-0.86	-1.67	-1.02	-0.68
Interest Expense	-0.95	-0.74	-0.63	-	-
Currency Exchange Gain (Loss)	-	-0	-0.13	-	-
EBT Excluding Unusual Items	-3.67	-1.6	-2.43	-1.02	-0.68
Other Unusual Items	-	-0.25	-0.02	-	-
Pretax Income	-3.67	-1.85	-2.45	-1.02	-0.68
Net Income	-3.67	-1.85	-2.45	-1.02	-0.68
Net Income to Common	-3.67	-1.85	-2.45	-1.02	-0.68
Shares Outstanding (Basic)	59	55	53	12	0
Shares Outstanding (Diluted)	59	55	53	12	0
Shares Change (YoY)	7.35%	4.86%	342.87%	60403.13%	-99.82%
EPS (Basic)	-0.06	-0.03	-0.05	-0.09	-34.93
EPS (Diluted)	-0.06	-0.03	-0.05	-0.09	-34.93
Free Cash Flow	-0.73	-0.64	-0.76	-0.81	-0.89
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.07	-45.51
Gross Margin	-	100.00%	99.48%	99.89%	97.24%
Operating Margin	-	-67.86%	-189.81%	-133.72%	-239.08%
Profit Margin	-	-145.44%	-278.55%	-133.72%	-239.08%
Free Cash Flow Margin	-	-50.55%	-86.16%	-106.78%	-311.50%
EBITDA	-2.71	-0.85	-1.64	-1	-0.67
EBITDA Margin	-	-66.56%	-186.63%	-130.84%	-234.30%
D&A For EBITDA	0.01	0.02	0.03	0.02	0.01
EBIT	-2.72	-0.86	-1.67	-1.02	-0.68
EBIT Margin	-	-67.86%	-189.81%	-133.72%	-239.08%

Updated Mar 14, 2008. Source: S&P Global Market Intelligence. Standard template. Financial Sources.